All patients N = 189 | eGFR≥45 N = 116 | eGFR< 45 N = 73 | p | |
---|---|---|---|---|
Follow-up duration, years | 310 | 188 | 122 | |
Cerebrovascular events, n (n/100py) | 3 (1.0) | 0 | 3 (2.5) | 0.09 |
• Stroke, n (n/100py) | 2 | 0 | 2 (1.6) | ns |
• TIA, n (n/100py) | 1 | 0 | 1 (0.8) | ns |
Bleeding complications, n (n/100py) | 5 (1.6) | 0 | 5 (4.1) | 0.06 |
• Intracranial bleeding | 0 | 0 | 0 | |
• Gastrointestinal bleeding | 1 (0.3) | 0 | 1 (0.8) | ns |
• Other bleeding | 4 (1.3) | 0 | 4 (3.3) | ns |
All-cause death, n (n/100py) | 8 (2.6) | 2 (1.1) | 6 (4.9) | ns |
• Cardiovascular death, n (n/100py) | 6 (1.9) | 2 (1.1) | 4 (3.3) | ns |
Periprocedural complications | ||||
• Pericardial effusion, n (%) | 0 | 0 | 0 | |
• DRT, n (%) | 12 (6.5) | 6 (3.2) | 6 (8.2) | ns |
• Other peri-procedural complications, n (%) | 4 (2.1) | 2 (1.7) | 2 (2.7) | ns |